Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase,
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, Embase, etc.,
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days
Home Articles Special Issues Volumes Webinars Videos

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

570 27 28

Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: Implications for optimized treatment

Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer 

Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

Drug resistance in targeted cancer therapies with RAF inhibitors

Advances in preclinical evaluation of experimental antibody drug conjugates

Articles

Most Recent | Most Viewed | Most Downloaded

Circular RNAs modulate cancer drug resistance: advances and challenges

Abstract:
Acquired drug resistance is a main factor contributing to cancer therapy failure and high cancer mortality, highlighting the necessity to develop novel... MORE
Jinghan Hua, ... Ping ZhaoPing Zhao
Open Access Review DOI: 10.20517/cdr.2024.195 27 Mar 2025
Views: Downloads:
Download PDF

Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML

Abstract:
Aim: Doxorubicin, pivotal for acute myeloid leukemia (AML) treatment, often succumbs to resistance, impeding therapeutic success. Although exosomal... MORE
Qianyuan LiQianyuan Li, ... Chenjiao Yao
Open Access Original Article DOI: 10.20517/cdr.2024.140 27 Mar 2025
Views: Downloads:
Download PDF

Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis

Abstract:
Cancer cells often develop tolerance to chemotherapy, targeted therapy, and immunotherapy drugs either before or during treatment. The significant... MORE
Leyi Yao, ... Dacai Xu
Open Access Review DOI: 10.20517/cdr.2025.41 26 Mar 2025
Views: Downloads:
Download PDF

Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

Abstract:
Cancer remains a significant global health challenge, with current chemotherapeutic strategies frequently limited by the emergence of resistance. In this... MORE
Chi Teng, ... Guo-Qing ChenGuo-Qing Chen
Open Access Review DOI: 10.20517/cdr.2024.178 23 Mar 2025
Views: Downloads:
Download PDF

Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types

Abstract:
Aim: As intrinsic resistance - often driven by concurrent genomic alterations in tumor suppressor genes or oncogenes - remains a major challenge in... MORE
Caterina Perfetto, ... Valerio CostaValerio Costa
Open Access Original Article DOI: 10.20517/cdr.2024.213 23 Mar 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Abstract:
Cancer is currently one of the most intractable diseases causing human death. Although the prognosis of tumor patients has been improved to a certain extent... MORE
Xiangyu Sun, ... Jianliang Shen
Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Abstract:
The emergence of chemoresistant disease during chemotherapy with 5-Fluorouracil-based (5-FU-based) regimens is an important factor in the mortality of... MORE
William H. Gmeiner, Charles Chidi Okechukwu
Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Abstract:
Recent advances in multiple myeloma therapy have increased the depth of response and ultimately survivals; however, the prognosis remains poor. The BCMA... MORE
Vincenzo SammartanoVincenzo Sammartano, ... Alessandro GozzettiAlessandro Gozzetti
Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Topic: Research on the Progress of Chemotherapy Resistance in Triple-Negative Breast Cancer

Prof. David A. Gewirtz

Submission Deadline: 15 Jun 2025

Published articles: 0

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Assoc. Prof. Dr. Fu Peng; Assoc. Prof. Dr. Xiaolu Wei

Submission Deadline: 19 May 2025

Published articles: 3

Godefridus J. Peters
Wafik El-Deiry
Liwu Fu
Elisa Giovannetti
Paola Perego
Chiara Riganti
Hailin Tang
Suresh V. Ambudkar
Farrukh Aqil
Yehuda G. Assaraf
Maria R. Baer
Stergios Boussios
Claudio Cerchione
Zhesheng Chen
Liang Cheng
William C Cho
Mario Cioce
Jacqueline Cloos
Paul Dent
Changming Dong
Thomas Efferth
Marco Falasca
David A. Gewirtz
Jean-Pierre Gillet
William Gmeiner
Michael M Gottesman
Alessandro Granito
Sanjay Gupta
Dominique Heymann
Yi Huang
Zhiqing Huang
Thomas E. Hutson
Gerrit Jansen
Dexin Kong
Hang Fai Kwok
Saverio Marchi
Enrico Mini
Gianpaolo Papaccio
Roger M. Phillips
Raphael E. Pollock
Paolo Ettore Porporato
Jiangjiang Qin
Robert W. Robey
Ahmad R Safa
John D. Schuetz
Gautam Sethi
John Seymour
Jianliang Shen
Dean G Tang
Kenneth Kin Wah To
Robert C.A.M. van Waardenburg
Erik A. C. Wiemer
Dong-Hua Yang
Xiaohe Yang
1 / 9
For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group
Topic: Tackling the Challenge of Drug Resistance in Lung Cancer
Topic: Microvesicle and Cancer Drug Resistance
Volume 8 (in progress)
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
New Media Partner!
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.
Webinar: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance
The webinar is scheduled for early May as an extension of the special issue.
We warmly welcome your participation and contributions.
Empowering Women in Science: Exclusive APC Discount for International Women's Day
This initiative not only recognizes the dedication of women in academia but also demonstrates our commitment to enhancing the participation of female scientists in high-impact research.
Women Scientists Driving Cancer Research: Articles from 2023-2024
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Announcement: Cancer Drug Resistance Best Paper Awards
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.
New Media Partner!
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.
Webinar: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance
The webinar is scheduled for early May as an extension of the special issue.
We warmly welcome your participation and contributions.

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: Implications for optimized treatment

Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer 

Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

Drug resistance in targeted cancer therapies with RAF inhibitors

Advances in preclinical evaluation of experimental antibody drug conjugates

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, ... Jianliang Shen
Open Access | Review | 19 Jun 2023
Views: | Downloads:
Download PDF
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
William H. Gmeiner, Charles Chidi Okechukwu
Open Access | Review | 28 Apr 2023
Views: | Downloads:
Download PDF
Anti-BCMA novel therapies for multiple myeloma
Vincenzo SammartanoVincenzo Sammartano, ... Alessandro GozzettiAlessandro Gozzetti
Open Access | Review | 21 Mar 2023
Views: | Downloads:
Download PDF

Topic: Research on the Progress of Chemotherapy Resistance in Triple-Negative Breast Cancer

Prof. David A. Gewirtz

Submission Deadline: 15 Jun 2025

Published articles: 0

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Assoc. Prof. Dr. Fu Peng; Assoc. Prof. Dr. Xiaolu Wei

Submission Deadline: 19 May 2025

Published articles: 3

Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties

Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.